1h Free Analyst Time
The pneumonia testing market is forecast to grow by $ 807.5 million during 2023-2028, accelerating at a CAGR of 5.69% during the forecast period. The report on the pneumonia testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of pneumonia and concerns associated with pneumonia mortality, development of advanced multiplex pc for pneumonia detection, and rise in geriatric population.
The pneumonia testing market is segmented as below:
By Product Type
- Consumables
- Analyzers
By Method
- Immunodiagnostics
- Molecular diagnostics
- Point-of-care testing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the pneumonia testing market covers the following areas:
- Pneumonia testing market sizing
- Pneumonia testing market forecast
- Pneumonia testing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Method
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global pneumonia testing market: Abbott Laboratories, Acumen Diagnostics Pte Ltd., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Danaher Corp., Diamedica SIA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, LGC Science Group Holdings Ltd., Meridian Bioscience Inc., OpGen Inc., Pfizer Inc., Quest Diagnostics Inc., Quidelortho Corp., Siemens AG, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing importance of promotional activities."
According to the report, one of the major drivers for this market is the rising prevalence of pneumonia and concerns associated with pneumonia mortality.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Acumen Diagnostics Pte Ltd.
- Becton Dickinson and Co.
- bioMerieux SA
- Bio Rad Laboratories Inc.
- Danaher Corp.
- Diamedica SIA
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Hologic Inc.
- Laboratory Corp. of America Holdings
- LGC Science Group Holdings Ltd.
- Meridian Bioscience Inc.
- OpGen Inc.
- Pfizer Inc.
- Quest Diagnostics Inc.
- Quidelortho Corp.
- Siemens AG
- Thermo Fisher Scientific Inc.
- Trinity Biotech Plc
